177 related articles for article (PubMed ID: 26452033)
1. Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
Ferreira-Teixeira M; Parada B; Rodrigues-Santos P; Alves V; Ramalho JS; Caramelo F; Sousa V; Reis F; Gomes CM
Oncotarget; 2015 Nov; 6(34):36185-201. PubMed ID: 26452033
[TBL] [Abstract][Full Text] [Related]
2. Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives.
Ohishi T; Koga F; Migita T
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729098
[TBL] [Abstract][Full Text] [Related]
3. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
[TBL] [Abstract][Full Text] [Related]
4. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
5. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer stem cells.
Tran MN; Goodwin Jinesh G; McConkey DJ; Kamat AM
Curr Stem Cell Res Ther; 2010 Dec; 5(4):387-95. PubMed ID: 20955163
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
Shafiei S; Kalantari E; Saeednejad Zanjani L; Abolhasani M; Asadi Lari MH; Madjd Z
Exp Mol Pathol; 2019 Jun; 108():164-172. PubMed ID: 31028726
[TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
13. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
14. Urothelial Carcinoma Stem Cells: Current Concepts, Controversies, and Methods.
Hatina J; Parmar HS; Kripnerova M; Hepburn A; Heer R
Methods Mol Biol; 2018; 1655():121-136. PubMed ID: 28889382
[TBL] [Abstract][Full Text] [Related]
15. Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.
Abugomaa A; Elbadawy M; Yamawaki H; Usui T; Sasaki K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963556
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in bladder cancer: a revisited and evolving concept.
Chan KS; Volkmer JP; Weissman I
Curr Opin Urol; 2010 Sep; 20(5):393-7. PubMed ID: 20657288
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-3 promotes muscle-invasive bladder cancer.
Han AL; Veeneman BA; El-Sawy L; Day KC; Day ML; Tomlins SA; Keller ET
Oncogene; 2017 Sep; 36(37):5243-5251. PubMed ID: 28504717
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
19. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.
Rebouissou S; Bernard-Pierrot I; de Reyniès A; Lepage ML; Krucker C; Chapeaublanc E; Hérault A; Kamoun A; Caillault A; Letouzé E; Elarouci N; Neuzillet Y; Denoux Y; Molinié V; Vordos D; Laplanche A; Maillé P; Soyeux P; Ofualuka K; Reyal F; Biton A; Sibony M; Paoletti X; Southgate J; Benhamou S; Lebret T; Allory Y; Radvanyi F
Sci Transl Med; 2014 Jul; 6(244):244ra91. PubMed ID: 25009231
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
